Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Mar 1, 2016

5262_dirs_2016-03-01_1315f9a1-d86e-4404-b6d6-85aa355525f6.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6692Q

GlaxoSmithKline PLC

01 March 2016

GlaxoSmithKline plc

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Share Value Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of a Person Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value of £13.9947 per Ordinary Share on 29 February 2016.  The sale was to meet tax liabilities following the vesting of the award granted in 2013 under the GlaxoSmithKline Share Value Plan (SVP).

Number of Ordinary Shares sold to meet tax liabilities following the vesting of a SVP award
Mrs V Whyte 6,143

The Company and PDMR were advised of these transactions on 1 March 2016.      

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 March 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBQXFZBBL